In particular, TNF can induce the activation of RIPK1 and downstream cascades and trigger necroptosis, although its significance in the loss of neurons in AD is still largely unstudied [21]; however, it opens another potential therapeutic aspect of the use of necroptosis inhibitors. This evidence concerns the gene RIPK1 and Alzheimer disease.